# US 2024/0254164 A1 · Purification of specific tripeptide by acidification

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0254164 A1
- Document ID: US20240254164A1
- Status: Published application
- Kind: A1
- Application number: 18/559,251
- Filed: 2022-05-03
- Published: 2024-08-01
- Earliest claimed: 2021-05-10
- Assignees: Dsm IP Assets B.V.
- Applicants: DSM IP Assets B.V.
- Inventors: Marc HEIDL; Thomas SCHAERER; Alexander SCHLIFKE-POSCHALKO
- Web page: https://patentgrep.com/patent/US20240254164A1

## CPC

- C07K 5/081: {the side chain containing O or S as heteroatoms, e.g. Cys, Ser}
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61Q 19/08: Anti-ageing preparations
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61K 2800/805: Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present invention relates to purification of a tripeptide of formula (I). By using said method, the tripeptide of formula (I) is obtained in a very pure form and due to this effect the purified tripeptide can be used in a variety of cosmetic and pharmaceutic compositions which are not accessible for the respective unpurified tripeptide.

## Claims

### Claim 1

A method of purification a tripeptide of the formula (I)
comprising the steps
a) providing a composition comprising a tripeptide of the formula (I)
b) forming an aqueous solution of the composition of step a)
c) bringing the composition of step b) to a pH≤2.5;
d) forming a precipitation of the tripeptide of the formula (I);
e) separating the precipitated tripeptide of the formula (I) formed in step d)
wherein
R1 represents either H or a C1-16-alkyl group or an aryl group or a C7-16-aralkyl group or a C7-16-alkylaryl group, which are optionally substituted by up to three hydroxy groups; and
R2 and R3
either represent independently from each other a C1-10-alkyl group, which are optionally substituted by up to three hydroxy groups;
or represent together a C2-10-alkylene group, which is optionally substituted by up to three hydroxy groups.

### Claim 2 (depends on 1)

The method according to claim 1, wherein
R1 is methyl or H,
R2 and R3 are both isopropyl.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the compound of the formula (I) is the compound of the formula (I-A)

### Claim 4 (depends on 1)

The method according to claim 1, wherein in step b) a sufficient amount of water, preferably in combination with a base, to the prepare a solution of a pH>3.

### Claim 5 (depends on 4)

The method according to claim 4, wherein step b) is performed at a temperature of between 10° C. and 30° C., preferably at ambient temperature.

### Claim 6 (depends on 5)

The method of claim 5, wherein in step d) acid is added to a pH≤2.5, preferably to a pH≤2, preferably at a temperature at a temperature of below 30° C., preferably between 30° C. and 1° C.

### Claim 7 (depends on 1)

The method according to a claim 1, wherein composition of step a) is present as in an acidified form and that in step b) water is added and heated to an elevated temperature, preferably to a temperature of more than 80° C., preferably to a temperature of between 80° C. and 100° C., more preferably to reflux temperature to form a solution at this temperature.

### Claim 8 (depends on 7)

The method according to claim 7, wherein step d) is performed by cooling the solution from the elevated temperature to a temperature of between 30° C. and 0° C., preferably of between 25° C. and 0° C.

### Claim 9 (depends on 1)

The method according to claim 1, wherein in step b) the composition is brought to a pH of ≤2.5, preferably of ≤2, by addition of a strong acid, preferably by HCl.

### Claim 10 (depends on 1)

The method according to claim 1, wherein the tripeptide of the formula (I) is prepared from the tripeptide of the formula (I0) by oxidation, particularly by oxidation with H2O2,

### Claim 11 (depends on 1)

A process of manufacturing a cosmetic or pharmaceutical composition comprising the steps
i) purifying a tripeptide of the formula (I) by a method according to claim 1, yielding a purified tripeptide of the formula (I);
ii) providing a cosmetically acceptable carrier
iii) combining the purified tripeptide of the formula (I) of step i) with the cosmetically acceptable carrier of step ii) and with optionally further ingredients to yield a cosmetic or pharmaceutical composition.

### Claim 12 (depends on 11)

A cosmetic or pharmaceutical composition which is produced according to a process according to claim 11.

### Claim 13 (depends on 1)

A cosmetic or pharmaceutical composition comprising a tripeptide of the formula (I)
which has been purified by a method according to claim 1, and a cosmetically acceptable carrier
wherein
R1 represents either H or a C1-16-alkyl group or an aryl group or a C7-16-aralkyl group or a C7-16-alkylaryl group, which are optionally substituted by up to three hydroxy groups; and
R2 and R3
either represent independently from each other a C1-10-alkyl group, which are optionally substituted by up to three hydroxy groups;
or represent together a C2-10-alkylene group, which is optionally substituted by up to three hydroxy groups.

### Claim 14 (depends on 1)

Use of a tripeptide of the formula (I), which is purified using a method according to claim 1, in a cometic composition
wherein
R1 represents either H or a C1-16-alkyl group or an aryl group or a C7-16-aralkyl group or a C7-16-alkylaryl group, which are optionally substituted by up to three hydroxy groups; and
R2 and R3
either represent independently from each other a C1-10-alkyl group, which are optionally substituted by up to three hydroxy groups;
or represent together a C2-10-alkylene group, which is optionally substituted by up to three hydroxy groups.
